
A study found that patients with T2D had increased risk of death with lower HbA1c. The conventional wisdom for the HbA1c target is to remain between 4% and 6% range.
However, a five-year follow-up data from the Accord trial confirms that it is better to target an HbAlc level between 7% and 7.5% rather than a lower value, in patients with T2D and a high risk of cardiovascular events.
For the record, it’s important to note that the patients in this study were at a high risk of cardiovascular events. The trial named ACCORD stands for “Action to Control Cardiovascular Risk in Diabetes”.
This article was based on the premise of a higher HbA1c for T2D glucose control in patients at high risk of cardiovascular events. In no way is this a hall pass for the bell curve of T2D people.
To describe the picture and parallel it to the story – leave the habit at home and slap on some SPF. Certain practices are more appropriate for certain people.
Visit Your Diabetes Health for more resources about health.
Bloggers
Media